Regencell Bioscience Holdings Limited Ordinary Shares
Symbol: RGC (NASDAQ)
Company Description:
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
- Today's Open: $15.425
- Today's High: $15.425
- Today's Low: $15.425
- Today's Volume: 147
- Yesterday Close: $15.45
- Yesterday High: $16.35
- Yesterday Low: $15.45
- Yesterday Volume: 114.76K
- Last Min Volume: 42
- Last Min High: $15.425
- Last Min Low: $15.425
- Last Min VWAP: $15.425
- Name: Regencell Bioscience Holdings Limited Ordinary Shares
- Website: https://www.regencellbioscience.com
- Listed Date: 2021-07-16
- Location: ,
- Market Status: Active
- CIK Number: 0001829667
- SIC Code:
- SIC description:
- Market Cap: $7.64B
- Round Lot: 100
- Outstanding Shares: 494.49M
- Asset Type: CS
Filing Date | Filing Type | Format |
---|---|---|
2025-07-11 | SCHEDULE 13D/A | View |
2025-06-30 | 6-K | View |
2025-06-30 | 6-K | View |
2025-06-17 | 6-K | View |
2025-06-02 | 6-K | View |
2025-03-13 | SCHEDULE 13D/A | View |
2025-01-15 | 6-K | View |
2024-10-25 | 20-F | View |
2024-06-20 | 6-K | View |
2024-01-02 | 6-K | View |
2023-12-15 | 6-K | View |
2023-10-27 | 20-F | View |
2023-06-15 | 6-K | View |
2023-06-05 | 6-K | View |
2023-03-17 | 6-K | View |
2023-02-28 | 6-K | View |
2023-01-04 | 6-K | View |
2022-12-22 | 6-K | View |
2022-10-31 | 20-F | View |
2022-09-12 | 6-K | View |